The Vote Worth More Than the Company

The Vote Worth More Than the Company

Since 1896, the Hoffmann-Oeri family has maintained strategic sovereignty over Roche through a governance structure that gives them 65% of voting rights while they hold roughly 8% of the company's economic value, controlling a CHF 60 billion pharmaceutical enterprise that their ancestors could never have funded alone.

Most founding families treat share ownership as the primary instrument of continuity.

The instinct is intuitive: more shares means more control, and control means legacy.

This approach creates a compounding vulnerability where each generation of inheritance, each outside investor brought in to fund growth, and each stock listing pursued for liquidity dilutes the founder's governing authority until the family becomes merely the largest shareholder among many equals.

Building legacy through governance architecture requires a more precise instrument than equity itself: the deliberate, structural separation of voting authority from economic participation.

Today, we examine how Fritz Hoffmann-La Roche's descendants engineered a dual-class ownership structure in 1928 and formalized a pooling agreement in 1948 that has given six generations of the Hoffmann-Oeri family strategic control over one of the world's largest healthcare companies, while public markets supplied the capital no single family could have assembled alone.

Case Study: How Roche Built a CHF 60 Billion Empire by Separating Vote From Value

When Fritz Hoffmann-La Roche founded F. Hoffmann-La Roche & Co. in Basel, Switzerland on October 1, 1896, at age 28, he was motivated less by competitive strategy than by the memory of suffering.

After witnessing the 1892 cholera epidemic in Hamburg, he became convinced that standardized, industrially manufactured medicines, not individually compounded apothecary preparations, represented the only path to reliable healthcare at scale.

His father, a silk merchant, provided the initial capital; his wife, Adele La Roche, contributed her dowry. By 1912, Roche operated in nine countries across three continents with more than 700 employees.

The First World War and the Russian Civil War nearly destroyed the enterprise. Supply chains collapsed, revenue evaporated, and by 1919 Roche was forced to restructure as a limited stock company to survive.

Fritz Hoffmann died on April 18, 1920, at age 51. As outside shareholders acquired equity stakes and the founding family’s inheritance dispersed across generations, the Hoffmanns faced the defining challenge of every multigenerational enterprise: the company one generation builds eventually requires capital no single family can supply, yet raising that capital dilutes the family’s authority.

The family that had created the institution was becoming its largest minority.

Roche’s response arrived in two phases.

In 1928, the company introduced a dual-class capital structure built around Genussscheine, non-voting participation certificates carrying full dividend rights but no governance power. Bearer shares carried voting authority. A family concentrating its holdings in bearer shares could govern the company while public markets supplied the capital.

The second pillar followed in 1948, when descendants of Fritz Hoffmann and the Oeri family formalized a pooling agreement binding members to vote their bearer shares as a unified block on major decisions. The architecture that would determine Roche’s next century was not a discovery in a laboratory. It was a decision about who holds the vote.

That structure mattered most when conditions were least forgiving.

In 2009, Roche launched what became the largest pharmaceutical acquisition in Swiss corporate history: a $46.8 billion bid for the outstanding public shares of Genentech, initiated eight months after the collapse of Lehman Brothers.

Observers described the commitment as structurally inadvisable: a company raising billions in new debt, executing a 4.4x revenue multiple transaction, during the worst financial crisis in a generation.

Roche had first acquired a 60% stake in Genentech in 1990. Completing the acquisition would give it full ownership of Herceptin, Avastin, and Rituxan, three cancer drugs that would define oncology treatment for the following decade.

The Hoffmann-Oeri family’s pooled voting position made the decision possible. On March 26, 2009, Roche completed the acquisition, paying $95 per share against Genentech’s 2008 revenues of $10.5 billion.

The four core Genentech drugs generated $21.1 billion in combined sales for Roche within the following decade, nearly half the acquisition price recovered in recurring annual revenues from a single product generation.

The transaction analysts had described as inadvisable became the foundational investment of Roche’s position as the world’s leading provider of cancer treatments.

The governance architecture demonstrated its resilience again in 2021. Novartis agreed to sell its 53.3 million Roche bearer shares back to the company for $20.7 billion, raising the family pool’s voting authority from approximately 45% to 67.5%.

Novartis had originally paid roughly $5 billion for its stake between 2001 and 2003, collected more than $6 billion in dividends across 20 years, and exited at an annualized return of 10.2%. Institutional capital captured the financial return while the founding family retained governing authority.

Today’s numbers confirm what governance continuity compounds.

In 2024, Roche generated group sales of CHF 60.5 billion, representing 7% growth at constant exchange rates. Oncology and hematology contributed CHF 23.7 billion. Research and development expenditure reached CHF 13 billion, 21.6% of revenue, a commitment level few activist-pressured public companies could sustain without concentrated voting authority.

Roche has increased its annual dividend for 38 consecutive years. As of December 31, 2024, the Hoffmann-Oeri pool held 64.97% of issued voting shares in a company whose financial scale no single family could underwrite.

The Hoffmann-Oeri family does not own Roche in any conventional sense.

As of 2025, they hold approximately 8-10% of total economic equity while exercising governance authority over a CHF 60 billion enterprise. Institutional investors and public shareholders bear most of the financial risk while the founding family determines strategic direction.

The architecture Fritz Hoffmann’s descendants designed achieved something patents and market share cannot replicate: the structural separation of the right to govern from the obligation to finance. 

For leaders and families contemplating multigenerational influence, Roche offers a profound inversion: the most enduring inheritance is not an economic stake but the authority to determine what the stake is for.

From Economic Ownership to Governance Authority

1. Design the Vote Before the Capital Arrives

The most consequential governance decisions in any family enterprise are made before the first outside investor signs a subscription agreement, not after.

Hermes International, the French luxury house controlled by the Hermes family across six generations, demonstrated this principle when LVMH began accumulating shares in 2010 through equity derivatives.

The family had already structured H51, a holding company pooling approximately 50% of shares under family control, making a hostile takeover structurally impossible without the family's consent.

The organization that designs its governance architecture before capital pressure arrives inherits the ability to refuse what money demands. 

What the Hermes family could not have constructed under pressure, they had already built in calm.

2. Pool the Votes Before the Family Disperses

The second and third generations of any founding family encounter the same structural erosion: inheritance dilutes voting stakes across siblings, cousins, and in-laws whose interests increasingly diverge from the founder's original mission.

Ford Motor Company, which structured its Class B shares to give the Ford family approximately 40% of voting rights with a minority economic stake in total equity, preserved strategic governance through five generations of family dispersal by binding the voting stake to a class of shares the public cannot acquire.

The family that pools votes before it disperses capital preserves the governing authority that equity dilution would otherwise dissolve across generations. 

A stake that cannot be purchased becomes the most enduring form of inheritance.

3. Separate Strategic Control From Operational Management

The governance architecture that enables long-term strategic independence requires a parallel commitment to professional management and the wisdom to distinguish which decisions belong to which domain.

Porsche SE, the holding company through which the Porsche and Piech families govern Volkswagen Group, maintains governance authority over a multi-brand automotive empire spanning Volkswagen, Audi, and Lamborghini, while day-to-day management rests with professional executives accountable to the public market.

When an owning family claims authority over strategic direction while releasing control of operational decisions, it creates the conditions under which professional excellence and family vision can coexist without compromise. 

The governance layer that governs without managing endures across leadership generations.

4. Let Institutional Capital Fund What Family Capital Preserves

The dual-class share structure's deepest insight is about the division of purpose between those who supply capital and those who hold governance.

Robert Bosch GmbH, the Stuttgart-based technology and engineering company structured through the Robert Bosch Stiftung, allows institutional parties to participate in the company's economic success while governance authority over the long-term direction remains insulated from any single investor's short-term preference.

The organization that structures its governance to separate strategic authority from economic entitlement creates a form of institutional permanence that no amount of capital can purchase, and no market cycle can erode. 

Ownership is temporary; governance architecture is perpetual.

From strategy to legacy

The governance structure the Hoffmann-Oeri family designed in 1928 and formalized in 1948 transformed a post-war restructuring into a 129-year dynasty, demonstrating that the most consequential legacy a founding family can build is not a company but the architecture of authority that determines what the company will become.

There is a particular form of foresight required to design governance for generations that will never meet you.

The 129-year Hoffmann-Oeri endurance reveals what patient architects understand: that the structures built before capital pressure arrives determine what can be preserved when it does.

Organizations mastering this discipline discover that the most defensible inheritance is not equity. It is authority.

Until next time.

- Legacy Beyond Profits